Look for:

Our offer for

AMGEN INC.


ISIN:
US0311621009
WKN:
031162100

- -
Price
-
Difference - (-)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeSIX Swiss Exchange
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)155,647 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)195.00 USD (3)
Ask (Ask size)- USD
Open-
High-
Low-
Close (prev. day)-
VWAP230.981 USD
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: AMGEN INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



- -
Price
-
Difference - (-)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeSIX Swiss Exchange
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)155,647 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)195.00 USD (3)
Ask (Ask size)- USD
Open-
High-
Low-
Close (prev. day)-
VWAP230.981 USD
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Performance and Risk

6m1Y3Y
Perf (%)---
Perf (abs.)---
Beta0.740.740.43
Volatility---
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)- USD (-)
Ø price 30 days | Ø volume 30 days (pcs.)- USD (-)
Ø price 100 days | Ø volume 100 days (pcs.)- USD (-)
Ø price 250 days | Ø volume 250 days (pcs.)- USD (-)
YTD High | date- USD (-)
YTD Low | date- USD (-)
52 Weeks High | date- USD (-)
52 Weeks Low | date- USD (-)

All listings for AMGEN INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/10/0417:35289.45 EUR0.0717
Vienna Stock Exchange2024/10/0417:32288.95 EUR0.0120
Tradegate2024/10/0422:26291.20 EUR0.6348
Stuttgart2024/10/0420:15289.55 EUR0.018
SIX Swiss Exchange---0.00-
SIX Swiss Exchange2022/11/1417:36180.00 CHF0.001
Nasdaq2024/10/0422:00319.66 USD468.6629,258
Munich2024/10/0421:22291.65 EUR0.012
London Stock Exchange2024/10/0417:35317.00 USD0.001
Hong Kong Stock Exchange2024/02/1602:151,850.00 HKD--
Hanover2024/10/0417:25289.00 EUR0.004
Hamburg2024/10/0417:25289.00 EUR0.004
Frankfurt2024/10/0421:35290.70 EUR0.054
Euronext Milan MTF Trading After Hours2024/10/0318:14297.75 EUR0.001
Euronext Milan MTF Global Equity Market2024/10/0417:44289.45 EUR0.001
Duesseldorf2024/10/0419:30290.80 EUR0.005
Berlin2024/10/0408:08287.50 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=151431&ID_TYPE_IMAGE_LOGO=2

Contact Details

AMGEN INC.
- -
One Amgen Center Drive - 91320-1799 Thousand Oaks
Telefon: +1-805-447-1000
Fax: +1-805-447-1010
E-mail: -

PDF Downloads

Company report: AMGEN INC.PDF Download

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Members of Management Board

Brian DrukerMember of Board of Directors
Mary KlotmanMember of Board of Directors
Michael DrakeMember of Board of Directors
Omar IshrakMember of Board of Directors
Tyler JacksMember of Board of Directors
Wanda AustinMember of Board of Directors
Amy MilesMember of Board of Directors
Charles HolleyMember of Board of Directors
Ellen KullmanMember of Board of Directors
Greg GarlandMember of Board of Directors
Robert EckertMember of Board of Directors
Robert A. BradwayChairman of Managing Board
David M. ReeseMember of Executive Committee
Jackie ElbonneMember of Executive Committee
James BradnerMember of Executive Committee
Jonathan GrahamMember of Executive Committee
Mike ZahiganMember of Executive Committee
Murdo GordonMember of Executive Committee
Paul BurtonMember of Executive Committee
Peter GriffithMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer